Biopharmaceuticals, also known as biologics, are a class of drugs that are produced using living cells or organisms. They are typically large, complex molecules, such as proteins, nucleic acids, or antibodies, that are used to treat a variety of diseases, including cancer, 自身免疫性疾病, and infectious diseases. Biopharmaceuticals are produced using biotechnology techniques, such as genetic engineering, fermentation, and cell culture. They are designed to target specific molecules or cells in the body, and may be more effective and have fewer side effects than traditional small molecule drugs. 根据最新估计, the global biopharmaceuticals market is set to achieve an incremental growth of USD 283.5 百万, 以近乎复合年增长率加速 7.99% 在预测期内 2023-2029.

该报告涵盖了市场规模和增长, 分割, 区域细分, 竞争格局, trends and strategies for global biopharmaceuticals market. 它提供了对市场的定量分析，使利益相关者能够利用当前的市场机会. 该报告还根据市场趋势和主要竞争对手的方法确定了最重要的机会和战略细分市场.

该行业报告提供了全球市场的市场估计和预测, 其次是对产品类型的详细分析, 应用, 和地区. The global market for biopharmaceuticals can be segmented by product type: 单克隆抗体, 重组生长因子, 纯化的蛋白质, 重组蛋白, 重组激素, 疫苗, 重组酶, 细胞和基因疗法, 合成免疫调节剂, 其他的. 据研究, the monoclonal antibodies segment had the largest share in the global biopharmaceuticals market. Biopharmaceuticals market is further segmented by application: 肿瘤学, 自身免疫性疾病, 炎症和传染病, 代谢紊乱, 其他治疗, 神经系统疾病, 心血管疾病, 荷尔蒙失调. 在 2022, the inflammatory and infectious diseases segment made up the largest share of revenue generated by the biopharmaceuticals market. 根据地区, the biopharmaceuticals market is segmented into: 北美, 欧洲, 亚太, 事物 (中东和非洲), 拉美. 在这些当中, 北美地区是全球收入最高的地区 2022.

The monoclonal antibodies market is further segmented into anti-cancer monoclonal antibodies, anti-inflammatory monoclonal antibodies, 其他的. The latest analysis indicates that the anti-cancer monoclonal antibodies segment occupied the largest share of this market in 2022 预计未来几年需求将达到最高. 此外, the recombinant hormones market has been categorized into recombinant human growth hormones, recombinant insulin, 其他的. 全球范围, the recombinant insulin segment made up the largest share of the biopharmaceuticals market. The vaccines market is further divided into recombinant vaccines, convectional vaccines. The recombinant vaccines segment was the largest contributor to the global biopharmaceuticals market in 2022. The recombinant growth factors market is further segmented into erythropoietin, granulocyte colony stimulating factor. The latest analysis indicates that the erythropoietin segment occupied the largest share of this market in 2022 预计未来几年需求将达到最高. 此外, the recombinant proteins market has been categorized into serum albumin, amyloid protein, defensin, transferrin. 全球范围, the transferrin segment made up the largest share of the biopharmaceuticals market.

市场细分
按产品类型: 单克隆抗体, 重组生长因子, 纯化的蛋白质, 重组蛋白, 重组激素, 疫苗, 重组酶, 细胞和基因疗法, 合成免疫调节剂, 其他的
按申请: 肿瘤学, 自身免疫性疾病, 炎症和传染病, 代谢紊乱, 其他治疗, 神经系统疾病, 心血管疾病, 荷尔蒙失调
按地区: 北美, 欧洲, 亚太, 事物 (中东和非洲), 拉美

The report also provides analysis of the key companies of the industry and their detailed company profiles including AbbVie Inc., Amgen Inc., 辉瑞公司, 诺华公司, Bristol Myers Squibb Company, Eli Lilly and Company, 约翰逊 & 约翰逊, Novo Nordisk AS, 葛兰素史克公司, F. Hoffmann-la Roche Ltd., Sanofi SA, Astrazeneca plc, 除其他外. 在这份报告中, 全面分析关键参与者及其策略，以了解市场的竞争前景.
*索取免费样品以获得完整的公司列表

报告范围
• To analyze and forecast the market size of the global biopharmaceuticals market.
• To classify and forecast the global biopharmaceuticals market based on product type, 应用, 地区.
• To identify drivers and challenges for the global biopharmaceuticals market.
• 检查竞争性发展，例如合并 & 收购, 协议, 合作与伙伴关系, ETC。, in the global biopharmaceuticals market.
• To identify and analyze the profile of leading players operating in the global biopharmaceuticals market.

为什么选择这份报告
• Gain a reliable outlook of the global biopharmaceuticals market forecasts from 2023 到 2029 跨场景.
• 确定投资的增长领域.
• 通过公司简介和市场数据保持领先于竞争对手.
• 以 Excel 格式进行跨场景分析的市场预估.
• 三个月的战略咨询和研究支持.
• 为单用户许可证提供打印验证.